Benchmarks finished Monday's choppy run mostly higher as
investor sentiment following new deals in the health care sector,
positive pending home sales data and intense selling pressure on
internet stocks. While merger and acquisition activity in the
health care sector helped the S&P 500 and Dow close in the
green, the Nasdaq ended in negative territory due to decline in
high-growth tech stocks.
For a look at the issues currently facing the markets, make sure
to read today's
Ahead of Wall Street
The Dow Jones Industrial Average (DJI) gained 0.5% to close
Monday's trading session at 16,448.74. The Standard & Poor
500 (S&P 500) went up 0.3% to finish at 1,869.43. The
tech-laden Nasdaq Composite Index dropped a meager 0.03% to
4,074.40. The fear-gauge CBOE Volatility Index (VIX) dropped 0.6%
to settle at 13.97. Total volume for the day was roughly 7.4
billion shares, higher than this month's average of 6.5 billion.
Advancing stocks outnumbered the decliners on the NYSE. For 50%
stocks that advanced, 46% declined.
Merger and acquisition activities in the health care sector
boosted investor sentiment. AstraZeneca PLC's (NYSE:
) shares surged 12.2% after Pfizer Inc. (NYSE:
) confirmed their interest to takeover AstraZeneca for about $100
billion. This is the second time Pfizer made a bid for Britain's
AstraZeneca. Pfizer led the advance among the Dow components.
Shares of Pfizer rose 4.2%.
In another development, Forest Laboratories has agreed to buy
drug development collaboration company Furiex Pharmaceuticals,
) for nearly $1.1 billion in cash. Shares of Furiex
Pharmaceuticals soared 28.6%. Bio-technology company Agenus Inc.
) signed a deal with Merck & Co. Inc. (NYSE:
). Shares of Agenus surged 19.5%. However, shares of Merck
The Health Care Select Sector SPDR (XLV) increased 0.6%. Major
drug manufacturing companies such as Johnson & Johnson (NYSE:
) and AbbVie Inc. (NYSE:
) rose 1.6% and 3.5%, respectively. Also, key bio-tech stocks
such as Gilead Sciences Inc. (NASDAQ:
), Vertex Pharmaceuticals Incorporated (NASDAQ:
) and Amgen Inc. (NASDAQ:
) increased 0.2%, 0.5% and 0.1%, respectively.
Investors were buoyed by encouraging economic data on pending
home sales. The National Association of Realtors reported that
Pending Home Sales Index, a forward looking indicator based on
contract signings, went up 3.4% to 97.4 in March. The rise in
pending home sales in March was way ahead of the consensus
expectation of a 0.6% increase.
The mixed bag of events caused wild swings in the benchmarks. The
Dow swung within a 187-point range. Declines in high-growth tech
stocks had a negative impact on Nasdaq. Stocks including
Amazon.com Inc. (NASDAQ:
), Facebook, Inc. (NASDAQ:
), Netflix, Inc. (NASDAQ:
), LinkedIn Corporation (NYSE:
) and Yelp, Inc. (NYSE:
) plunged 2.4%, 2.7%, 2.4%, 6.4% and 3.6%, respectively.
However, gains in certain technology bellwethers helped restrict
the negative impact from the selloff. The Technology Select
Sector SPDR (XLK) increased 0.9%. Shares of Apple Inc. (NASDAQ:
), the largest component of both the Nasdaq and S&P 500,
gained 3.9%. Other bellwethers such as Microsoft Corporation
), Google Inc. (NASDAQ:
), International Business Machines Corporation (NYSE:
) and Verizon Communications Inc. (NYSE:
) gained 2.4%, 0.2%, 1.9% and 1.4%, respectively.
Six out of 10 sectors of the S&P 500 ended in the green. The
Consumer Staples Select Sector SPDR (XLP) led the advance as the
sector rose 1.1%. Key stocks from the sector such as The Procter
& Gamble Company (NYSE:
), Philip Morris International, Inc. (NYSE:
), Wal-Mart Stores Inc. (NYSE:
), CVS Caremark Corporation (NYSE:
) and Pepsico, Inc. (NYSE:
) increased 1.9%, 1.0%, 1.5%, 0.5% and 1.8%, respectively.
ABBVIE INC (ABBV): Free Stock Analysis Report
AGENUS INC (AGEN): Free Stock Analysis Report
AMGEN INC (AMGN): Free Stock Analysis Report
AMAZON.COM INC (AMZN): Free Stock Analysis
ASTRAZENECA PLC (AZN): Free Stock Analysis
FACEBOOK INC-A (FB): Free Stock Analysis
FURIEX PHARMACT (FURX): Free Stock Analysis
GILEAD SCIENCES (GILD): Free Stock Analysis
JOHNSON & JOHNS (JNJ): Free Stock Analysis
LINKEDIN CORP-A (LNKD): Free Stock Analysis
MERCK & CO INC (MRK): Free Stock Analysis
NETFLIX INC (NFLX): Free Stock Analysis
PFIZER INC (PFE): Free Stock Analysis Report
VERTEX PHARM (VRTX): Free Stock Analysis
To read this article on Zacks.com click here.